Author Question: James is a clinical researcher who is interested in methods for reducing the intrusiveness of ... (Read 133 times)

Davideckstein7

  • Hero Member
  • *****
  • Posts: 555
James is a clinical researcher who is interested in methods for reducing the intrusiveness of auditory hallucinations in individuals with paranoid schizophrenia. He has three treatments: dialectical behavioral therapy (DBT), medication, and deep brain stimulation (DBS). He also has three treatment settings: inpatient, day hospital, and outpatient. Although the participants in all three settings can receive DBT and medication, only those who are inpatient can receive DBS. As a result, James has a total of seven groups: DBT-Inpatient, DBT-Day Hospital, DBT-Outpatient, Medication-Inpatient, Medication-Day Hospital, Medication-Outpatient, and DBS-Inpatient. This design is best classified as a(n) ____ factorial.
 
  a. imperfect
 b. incomplete
  c. partial
 d. limited

Question 2

The use of nonsense syllables was not a perfect solution to the problems Ebbinghaus hoped to avoid by their use because
 
  a. nonsense syllables are hard to learn.
  b. he was the only subject in his experiments.
  c. meaning may be attached to nonsense syllables.
  d. none of these



pallen55

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

b

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

For a complete list of videos, visit our video library